Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons
Public ClinicalTrials.gov record NCT00451074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Six Month Randomized, Clinical Trial of Gentamicin in Duchenne Muscular Dystrophy Subjects With Stop Codon Mutations
Study identification
- NCT ID
- NCT00451074
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Enrollment
- 12 participants
Conditions and interventions
Conditions
Interventions
- Gentamicin infusions twice a week for six months Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 20 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2007
- Primary completion
- Jun 30, 2009
- Completion
- Jun 30, 2009
- Last update posted
- Mar 22, 2012
2007 – 2009
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neuromuscular Research Institute - Scottsdale Healthcare Hopsital at Shea | Scottsdale | Arizona | 85258 | — |
| University of Kansas | Kansas City | Kansas | 66160-0001 | — |
| The Research Institute at Nationwide Children's Hospital | Columbus | Ohio | 43205-2696 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00451074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2012 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00451074 live on ClinicalTrials.gov.